BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,030 | -58.4% | 4,024 | -49.9% | 0.02% | -58.3% |
| Q2 2023 | $365,790 | +6.6% | 8,025 | -5.2% | 0.04% | 0.0% |
| Q1 2023 | $343,266 | +125.8% | 8,463 | +183.7% | 0.04% | +111.8% |
| Q4 2022 | $152,050 | -32.1% | 2,983 | -28.3% | 0.02% | -43.3% |
| Q3 2022 | $224,000 | -3.0% | 4,161 | +15.9% | 0.03% | -3.2% |
| Q2 2022 | $231,000 | -2.1% | 3,589 | +17.6% | 0.03% | +6.9% |
| Q1 2022 | $236,000 | -18.9% | 3,051 | -10.0% | 0.03% | -17.1% |
| Q4 2021 | $291,000 | +3.6% | 3,389 | -2.9% | 0.04% | -10.3% |
| Q3 2021 | $281,000 | +0.7% | 3,490 | +0.7% | 0.04% | -2.5% |
| Q2 2021 | $279,000 | +2.2% | 3,466 | +7.2% | 0.04% | -9.1% |
| Q1 2021 | $273,000 | +27.6% | 3,234 | +21.2% | 0.04% | +10.0% |
| Q4 2020 | $214,000 | 0.0% | 2,668 | +0.1% | 0.04% | -14.9% |
| Q3 2020 | $214,000 | -10.8% | 2,666 | -4.4% | 0.05% | -11.3% |
| Q2 2020 | $240,000 | -14.6% | 2,788 | -19.3% | 0.05% | +12.8% |
| Q1 2020 | $281,000 | +30.1% | 3,454 | +22.8% | 0.05% | +80.8% |
| Q4 2019 | $216,000 | +4.9% | 2,812 | +13.4% | 0.03% | -18.8% |
| Q3 2019 | $206,000 | +6.2% | 2,480 | 0.0% | 0.03% | +3.2% |
| Q2 2019 | $194,000 | -19.8% | 2,480 | -20.1% | 0.03% | -27.9% |
| Q1 2019 | $242,000 | +86.2% | 3,105 | +48.4% | 0.04% | +22.9% |
| Q4 2018 | $130,000 | -14.5% | 2,093 | -0.8% | 0.04% | -18.6% |
| Q3 2018 | $152,000 | +4.1% | 2,110 | 0.0% | 0.04% | -15.7% |
| Q2 2018 | $146,000 | +7.4% | 2,110 | -8.4% | 0.05% | +4.1% |
| Q1 2018 | $136,000 | +9.7% | 2,303 | +9.6% | 0.05% | 0.0% |
| Q4 2017 | $124,000 | -6.1% | 2,101 | -7.7% | 0.05% | -9.3% |
| Q3 2017 | $132,000 | +13.8% | 2,277 | +3.9% | 0.05% | +5.9% |
| Q2 2017 | $116,000 | +2.7% | 2,192 | -6.5% | 0.05% | +2.0% |
| Q1 2017 | $113,000 | +17.7% | 2,344 | +1.3% | 0.05% | +4.2% |
| Q4 2016 | $96,000 | -8.6% | 2,313 | -1.1% | 0.05% | -29.4% |
| Q3 2016 | $105,000 | +5.0% | 2,339 | 0.0% | 0.07% | -1.4% |
| Q2 2016 | $100,000 | -21.9% | 2,339 | -27.5% | 0.07% | -16.9% |
| Q1 2016 | $128,000 | +11.3% | 3,224 | +0.3% | 0.08% | +3.8% |
| Q4 2015 | $115,000 | +79.7% | 3,214 | +54.7% | 0.08% | +81.8% |
| Q3 2015 | $64,000 | -59.2% | 2,078 | -11.0% | 0.04% | -56.0% |
| Q2 2015 | $157,000 | – | 2,336 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |